| NO |
Title |
Date |
Submission Obligator |
| 10 |
Reporting reasons for holding general shareholders' meeting on the most concentrated date |
2019/03/07 |
HANALL BIOPHARMA CO.,LTD |
| 9 |
Decision on Calling Shareholders' Meeting |
2019/03/06 |
HANALL BIOPHARMA CO.,LTD |
| 8 |
Submission of Audit Report |
2019/03/06 |
HANALL BIOPHARMA CO.,LTD |
| 7 |
Organization of Investor Relations Event |
2019/02/21 |
HANALL BIOPHARMA CO.,LTD |
| 6 |
Implementation and Operation of Compliance Program of the Fair Trade Commission |
2019/02/08 |
HANALL BIOPHARMA CO.,LTD |
| 5 |
30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) |
2019/01/14 |
HANALL BIOPHARMA CO.,LTD |
| 4 |
Closure of Stock Transfer (Shareholder's Registry) |
2018/12/14 |
HANALL BIOPHARMA CO.,LTD |
| 3 |
Organization of Investor Relations Event |
2018/11/27 |
HANALL BIOPHARMA CO.,LTD |
| 2 |
Organization of Investor Relations Event |
2018/11/26 |
HANALL BIOPHARMA CO.,LTD |
| 1 |
Organization of Investor Relations Event |
2018/10/11 |
HANALL BIOPHARMA CO.,LTD |